首页> 外文学位 >c-Rel deficiency and its effect on proliferation and survival in immunodeficient lymphoblastic B cells.
【24h】

c-Rel deficiency and its effect on proliferation and survival in immunodeficient lymphoblastic B cells.

机译:c-Rel缺乏及其对免疫缺陷淋巴细胞B细胞增殖和存活的影响。

获取原文
获取原文并翻译 | 示例

摘要

The analysis of lymphocytes from immunodeficient patients has provided valuable insights into understanding the development and function of the immune system. In particular, studies of patients with Hyper IgM syndrome, a rare immunodeficiency resulting from defects in both CD40L in activated CD4+ T cells and components of the CD40 signaling pathway in B cells have been crucial for the elucidation of molecular pathways involved in the activation, proliferation and differentiation of B lymphocytes. Previously our lab generated EBV transformed lymphoblastic cells with inducible LMP1 from a female patient diagnosed with non-X-linked HIGM (Pt1-LCLtet cells, Pt1). Analysis of these cells revealed a CD40-specific activation defect associated with low c-Rel levels. To broaden our understanding of the Pt1 phenotype we analyzed c-Rel expression and found that low c-Rel levels were the outcome of depressed transcriptional activation of the c-rel promoter. In-vivo analysis revealed that low transcription was coincident with increased p65 activity at the c- rel promoter although this was insufficient to induce normal c-Rel expression. Further investigations of the Pt1-LCLtet cells uncovered a proliferation and survival defect characterized by reduced c-Myc transcription and increased levels of caspase-4. This defect was complemented after c-Rel overexpression, supporting a causative role for c-Rel deficiency in the observed phenotype of the Pt1-LCLtet cells. The LCL tet cells were further utilized as a model system for the independent analysis of LMP1 and CD40 signaling. These studies revealed several outcomes of LMP1 signaling in the biology and function of CD40. Specifically, LMP1 signaling induced a unique pattern of CD40 phosphorylation as well as the expression of several novel CD40 isoforms. Moreover, when CD40 and LMP1 were activated simultaneously a synergistic effect was observed towards p65 and p38 phosphorylation suggesting a functional interaction that might occur during early stages of EBV infection or malignant transformation where both LMP1 and CD40 are co-expressed in the infected cell. Collectively, our results demonstrate that a majority of the defects displayed in the Pt1-LCL tet cells are a result of reduced c-Rel expression. Importantly, these results ascribe c-Rel a novel function as a negative regulator of caspase-4 expression and a putative key player in the control of cell survival in EBV-immortalized B cells.
机译:对免疫缺陷患者淋巴细胞的分析为了解免疫系统的发育和功能提供了宝贵的见解。特别是对患有高IgM综合征的患者的研究,这种疾病是由激活的CD4 + T细胞中的CD40L和B细胞中的CD40信号通路的缺陷导致的罕见免疫缺陷,对于阐明与激活,增殖有关的分子通路至关重要和B淋巴细胞的分化。以前,我们的实验室从一名诊断为非X连锁HIGM的女性患者(Pt1-LCLtet细胞,Pt1)中产生了具有可诱导LMP1的EBV转化淋巴细胞。这些细胞的分析显示与低c-Rel水平相关的CD40特异性激活缺陷。为了拓宽我们对Pt1表型的理解,我们分析了c-Rel表达,发现低c-Rel水平是c-rel启动子转录激活受抑制的结果。体内分析表明,低转录与c-rel启动子上p65活性的增加同时发生,尽管这不足以诱导正常的c-Rel表达。对Pt1-LCLtet细胞的进一步研究发现了以c-Myc转录减少和caspase-4水平升高为特征的增殖和生存缺陷。此缺陷在c-Rel过表达后得到了补充,支持了c-Rel缺乏在观察到的Pt1-LCLtet细胞表型中的原因。 LCL tet细胞被进一步用作独立分析LMP1和CD40信号的模型系统。这些研究揭示了LMP1信号传导在CD40的生物学和功能中的几种结果。具体而言,LMP1信号传导诱导了CD40磷酸化的独特模式以及几种新型CD40同工型的表达。此外,当同时激活CD40和LMP1时,观察到了对p65和p38磷酸化的协同作用,表明可能在EBV感染或恶性转化的早期阶段发生了功能相互作用,其中LMP1和CD40在感染的细胞中共表达。总的来说,我们的结果表明,Pt1-LCL tet细胞中显示的大多数缺陷是c-Rel表达降低的结果。重要的是,这些结果将c-Rel赋予caspase-4表达的负调节剂和在EBV永生化B细胞中控制细胞存活的关键关键角色。

著录项

  • 作者

    Valentin Acevedo, Anibal J.;

  • 作者单位

    Rutgers The State University of New Jersey - New Brunswick and University of Medicine and Dentistry of New Jersey.;

  • 授予单位 Rutgers The State University of New Jersey - New Brunswick and University of Medicine and Dentistry of New Jersey.;
  • 学科 Biology Molecular.;Health Sciences Immunology.;Biology Cell.
  • 学位 Ph.D.
  • 年度 2011
  • 页码 156 p.
  • 总页数 156
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号